These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 37959843)

  • 1. Double Attack to Oxidative Stress in Neurodegenerative Disorders: MAO-B and Nrf2 as Elected Targets.
    Basagni F; Di Paolo ML; Cozza G; Dalla Via L; Fagiani F; Lanni C; Rosini M; Minarini A
    Molecules; 2023 Nov; 28(21):. PubMed ID: 37959843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nrf2-induced antioxidant protection: a promising target to counteract ROS-mediated damage in neurodegenerative disease?
    de Vries HE; Witte M; Hondius D; Rozemuller AJ; Drukarch B; Hoozemans J; van Horssen J
    Free Radic Biol Med; 2008 Nov; 45(10):1375-83. PubMed ID: 18824091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel bifunctional drugs targeting monoamine oxidase inhibition and iron chelation as an approach to neuroprotection in Parkinson's disease and other neurodegenerative diseases.
    Youdim MB; Fridkin M; Zheng H
    J Neural Transm (Vienna); 2004 Oct; 111(10-11):1455-71. PubMed ID: 15480846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of modulation of antioxidant enzyme systems in the treatment of neurodegenerative diseases.
    Obuobi S; Karatayev S; Chai CL; Ee PL; Mátyus P
    J Enzyme Inhib Med Chem; 2016; 31(sup3):194-204. PubMed ID: 27389167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nrf2-ARE pathway: An emerging target against oxidative stress and neuroinflammation in neurodegenerative diseases.
    Buendia I; Michalska P; Navarro E; Gameiro I; Egea J; León R
    Pharmacol Ther; 2016 Jan; 157():84-104. PubMed ID: 26617217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel multifunctional neuroprotective iron chelator-monoamine oxidase inhibitor drugs for neurodegenerative diseases: in vitro studies on antioxidant activity, prevention of lipid peroxide formation and monoamine oxidase inhibition.
    Zheng H; Gal S; Weiner LM; Bar-Am O; Warshawsky A; Fridkin M; Youdim MB
    J Neurochem; 2005 Oct; 95(1):68-78. PubMed ID: 16181413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The principal molecular mechanisms behind the activation of Keap1/Nrf2/ARE pathway leading to neuroprotective action in Parkinson's disease.
    Chakkittukandiyil A; Sajini DV; Karuppaiah A; Selvaraj D
    Neurochem Int; 2022 Jun; 156():105325. PubMed ID: 35278519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Nrf2-ARE Signalling pathway: promising drug target to combat oxidative stress in neurodegenerative disorders.
    van Muiswinkel FL; Kuiperij HB
    Curr Drug Targets CNS Neurol Disord; 2005 Jun; 4(3):267-81. PubMed ID: 15975029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Overview of the Nrf2/ARE Pathway and Its Role in Neurodegenerative Diseases.
    Zgorzynska E; Dziedzic B; Walczewska A
    Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel Series of Dual NRF2 Inducers and Selective MAO-B Inhibitors for the Treatment of Parkinson's Disease.
    Duarte P; Michalska P; Crisman E; Cuadrado A; León R
    Antioxidants (Basel); 2022 Jan; 11(2):. PubMed ID: 35204129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the Keap1/Nrf2 pathway in neurodegenerative diseases.
    Yamazaki H; Tanji K; Wakabayashi K; Matsuura S; Itoh K
    Pathol Int; 2015 May; 65(5):210-9. PubMed ID: 25707882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotective and antioxidative effects of pioglitazone in brain tissue adjacent to the ischemic core are mediated by PI3K/Akt and Nrf2/ARE pathways.
    Zhao Y; Lützen U; Gohlke P; Jiang P; Herdegen T; Culman J
    J Mol Med (Berl); 2021 Aug; 99(8):1073-1083. PubMed ID: 33864097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of Dithiolethiones and Identification of Potential Neuroprotective Agents via Activation of Nrf2-Driven Antioxidant Enzymes.
    Song ZL; Bai F; Zhang B; Fang J
    J Agric Food Chem; 2020 Feb; 68(7):2214-2231. PubMed ID: 31986030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidative Stress and Antioxidants in Neurological Diseases: Is There Still Hope?
    Carvalho AN; Firuzi O; Gama MJ; Horssen JV; Saso L
    Curr Drug Targets; 2017 Mar; 18(6):705-718. PubMed ID: 27033198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antioxidative defense mechanisms controlled by Nrf2: state-of-the-art and clinical perspectives in neurodegenerative diseases.
    Lim JL; Wilhelmus MM; de Vries HE; Drukarch B; Hoozemans JJ; van Horssen J
    Arch Toxicol; 2014 Oct; 88(10):1773-86. PubMed ID: 25164826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Nrf2-ARE pathway: an indicator and modulator of oxidative stress in neurodegeneration.
    Johnson JA; Johnson DA; Kraft AD; Calkins MJ; Jakel RJ; Vargas MR; Chen PC
    Ann N Y Acad Sci; 2008 Dec; 1147():61-9. PubMed ID: 19076431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bifunctional drug derivatives of MAO-B inhibitor rasagiline and iron chelator VK-28 as a more effective approach to treatment of brain ageing and ageing neurodegenerative diseases.
    Youdim MB; Fridkin M; Zheng H
    Mech Ageing Dev; 2005 Feb; 126(2):317-26. PubMed ID: 15621213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New melatonin-cinnamate hybrids as multi-target drugs for neurodegenerative diseases: Nrf2-induction, antioxidant effect and neuroprotection.
    Buendia I; Navarro E; Michalska P; Gameiro I; Egea J; Abril S; López A; González-Lafuente L; López MG; León R
    Future Med Chem; 2015; 7(15):1961-9. PubMed ID: 26496465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of monoamine oxidase-B by selegiline reduces cigarette smoke-induced oxidative stress and inflammation in airway epithelial cells.
    Cui Y; Liu KW; Liang Y; Ip MS; Mak JC
    Toxicol Lett; 2017 Feb; 268():44-50. PubMed ID: 28108387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type A and B monoamine oxidase in age-related neurodegenerative disorders: their distinct roles in neuronal death and survival.
    Naoi M; Maruyama W; Inaba-Hasegawa K
    Curr Top Med Chem; 2012; 12(20):2177-88. PubMed ID: 23231395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.